ストックスクリーナーアプリを入手
0.0502
0.00%
0.00
アフターアワーズ：
.05
-0.0002
-0.40%
前日終値:
$0.0502
開ける：
$0.05
24時間の取引高:
81.57M
Relative Volume:
0.45
時価総額：
$305.06K
収益：
-
当期純損益:
$-33.44M
株価収益率:
-0.00313
EPS:
-16.0242
ネットキャッシュフロー:
$-28.30M
1週間 パフォーマンス:
-16.75%
1か月 パフォーマンス:
-61.74%
6か月 パフォーマンス:
-95.48%
1年 パフォーマンス:
-98.36%
1日の値動き範囲:
$0.0485
$0.0536
1週間の範囲:
$0.0443
$0.0745
52週間の値動き範囲:
$0.0325
$10.79
Nucana Plc Adr Stock (NCNA) Company Profile
NCNA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NCNA
Nucana Plc Adr
|
0.0502 | 23.01M | 0 | -33.44M | -28.30M | -16.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.55 | 123.00B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.93 | 59.66B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.81 | 41.84B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.92 | 33.98B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
279.16 | 27.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Nucana Plc Adr Stock (NCNA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-30 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2022-03-03 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-10-22 | 開始されました | Truist | Buy |
| 2020-07-24 | 開始されました | Oppenheimer | Outperform |
| 2019-08-19 | 開始されました | H.C. Wainwright | Buy |
| 2018-10-19 | 開始されました | Piper Jaffray | Overweight |
| 2017-10-23 | 開始されました | Citigroup | Buy |
| 2017-10-23 | 開始されました | Jefferies | Buy |
| 2017-10-23 | 開始されました | William Blair | Outperform |
すべてを表示
Nucana Plc Adr (NCNA) 最新ニュース
NCNA’s Market Whiplash: -98.30% YTD Decline, -65.02% Plunge in 30 Days - investchronicle.com
NuCana (NCNA) Announces 1-for-200 Reverse ADS Split Effective Aug 8 2025 - Stock Titan
NuCana enters $100 million at-the-market sales agreement for ADS offering - Investing.com
NuCana CEO takes leave of absence due to health reasons - Investing.com
Market Insight: RxSight Inc (RXST)’s Notable Drop, Closing at 13.50 - DWinneX
The Future of NuCana plc ADR: Analyzing NCNA - investchronicle.com
nucana plc announces annual report release and upcoming agm - Investing.com India
NuCana's Melanoma Breakthrough: Key Drug Advances to Expansion Trial, Q1 Losses Drop 63% Year-over-Year - Stock Titan
Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Benzinga
NuCana prices $7 million direct offering of ADSs and warrants - Investing.com
NuCana prices $7 million direct offering of ADSs and warrants By Investing.com - Investing.com India
New Outlook On NuCana plc ADR - Stocksregister
NCNA’s Stock Journey: What Investors Need to Know About NuCana plc ADR’s Performance - investchronicle.com
Do investors need to be concerned about Cadiz Inc (CDZI)? - uspostnews.com
Natera Inc (NTRA) deserves closer scrutiny - uspostnews.com
Weave Communications Inc (WEAV) produces promising results - uspostnews.com
Investing in NuCana plc ADR (NCNA) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com
Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season? - Nasdaq
Post-Trade Analysis: NuCana plc ADR (NCNA) Slides -26.97, Closing at 0.65 - DWinneX
Closing Bell Recap: Yxt.Com Group Holding Ltd. ADR (YXT) Ends at 0.56, Reflecting a -14.42 Downturn - DWinneX
In the Green: Gogoro Inc (GGR) Closes at 0.26, Up/Down 0.08 from Previous Day - DWinneX
Daily Market Movement: Tivic Health Systems Inc (TIVC) Sees a 1.88 Increase, Closing at 7.04 - DWinneX
RLYB Ends Pregnancy-Related Rare Disease Program, Stock Tanks - Barchart.com
Stock Update - Investorsobserver
NuCana Reports Strong Phase 2 Data: 75% Disease Control in Melanoma Trial, Lower Q3 Loss - StockTitan
NuCana Stock Soars 151% on Upbeat Efficacy Data From Melanoma Study - Yahoo Finance
NuCana stock downgraded by William Blair after halted cancer study - Investing.com
NuCana shares receive $150 stock PT at Oppenheimer on upbeat trial prospects - Investing.com
NuCana regains Nasdaq compliance with bid price rule - Investing.com
NuCana: Potential Turnaround In 2024 But Risky - Seeking Alpha
NuCana plcADR (NCNA) Price Target Increased by 15.39% to 5.10 - Nasdaq
Here's Why NuCana PLC Sponsored ADR (NCNA) is Poised for a Turnaround After Losing 26.5% in 4 Weeks - Nasdaq
Down 34.6% in 4 Weeks, Here's Why You Should You Buy the Dip in NuCana PLC Sponsored ADR (NCNA) - Nasdaq
Down 57.3% in 4 Weeks, Here's Why You Should You Buy the Dip in NuCana PLC Sponsored ADR (NCNA) - Nasdaq
ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire
NuCana (NCNA) Looks Good: Stock Adds 5.7% in Session - Yahoo Finance
Cboe U.S. Equities Exchanges Overview - Cboe Global Markets
Will NuCana Continue to Surge Higher? - Nasdaq
NuCana (NCNA) Stock Price, News & Analysis - MarketBeat
NCNA Stock Price and Chart — NASDAQ:NCNA - TradingView
NuCana PLC Stock Price Today | NASDAQ: NCNA Live - Investing.com
Nucana Plc Adr (NCNA) 財務データ
収益
当期純利益
現金流量
EPS
3.40%
2.49%
大文字化:
|
ボリューム (24 時間):